Genome British Columbia (Genome BC) has announced an innovative initiative aimed at integrating genetic counsellors into primary care settings across the province. This project, led by Dr. Jehannine (J9) Austin of the University of British Columbia, is set to transform patient care by addressing health inequities and providing personalized care through precision medicine.
The ACCESS-GC trial, funded by Genome BC, seeks to embed genetic counsellors (GCs) directly into family physician clinics, enabling a team-based approach to patient care. By doing so, it aims to meet the growing demands on BC’s healthcare system, especially as an aging population and increasingly complex health needs put pressure on family physicians.
“Genome BC is committed to driving innovations that tackle real-world healthcare challenges,” says Dr. Federica Di Palma, Chief Scientific Officer of Genome BC. “The ACCESS-GC trial is a crucial step toward ensuring that all British Columbians have access to cutting-edge genetic care, regardless of where they live.”
Traditionally, genetic counsellors have been based in urban hospitals, creating long wait times and access barriers, particularly in rural and underserved areas. The ACCESS-GC trial hopes to address these disparities by embedding genetic expertise into primary care, providing more timely and equitable access to precision medicine.
The trial will assess the impact of this integrated model on conditions with genetic components, including rare diseases, diabetes, and psychiatric disorders, while also evaluating its economic and systemic benefits. If successful, this model could redefine how genetic services are delivered, making precision medicine more accessible across BC.
Leave a Reply